Find trials
Search tips

Outcomes Following Stereotactic Radiosurgery for Patients with Glomus Jugulare Tumors

Overview

About this study

The purpose of this study is to describe long-term hearing outcomes following stereotactic radiosurgery (SRS) for glomus jugulare tumors (GJT).

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • All adult patients who underwent primary SRS, salvage SRS (defined as SRS after prior surgical or non-surgical treatment), or SRS after intentional cytoreductive subtotal resection between 1990 and 2016

Exclusion Criteria: 

  • Patients under the age of 18 years
  • Those who refuse study participation or MN Research Authorization

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Matthew Carlson, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20307106

Mayo Clinic Footer